AMP Rheumatoid Arthritis and Systemic Lupus Erythematosus
GPTKB entity
Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
research
|
| gptkbp:collaboratesWith |
gptkb:National_Institutes_of_Health_(NIH)
non-profit organizations biopharmaceutical companies |
| gptkbp:focusesOn |
gptkb:systemic_lupus_erythematosus
rheumatoid arthritis |
| gptkbp:goal |
identify and validate drug targets
|
| https://www.w3.org/2000/01/rdf-schema#label |
AMP Rheumatoid Arthritis and Systemic Lupus Erythematosus
|
| gptkbp:partOf |
gptkb:Accelerating_Medicines_Partnership_(AMP)
|
| gptkbp:startYear |
2014
|
| gptkbp:studies |
immune system cells in affected tissues
|
| gptkbp:uses |
genomics
bioinformatics single-cell analysis |
| gptkbp:website |
https://www.nih.gov/research-training/accelerating-medicines-partnership-amp/rheumatoid-arthritis-systemic-lupus-erythematosus
|
| gptkbp:bfsParent |
gptkb:Foundation_for_the_National_Institutes_of_Health
|
| gptkbp:bfsLayer |
6
|